• Novo Nordisk announced that due to significant demands, they are only able to supply limited quantities of 0.25 mg, 0.5 mg, and 1 mg dose strengths of Wegovy to wholesalers for distribution to retail pharmacies, this is acknowledged to have now causes a national shortage of medication.  Novo Nordisk anticipates shortage to last through September 2023.
      • Currently, the 1.7 mg and 2.4 mg dose strengths of Wegovy® are available Supply update (novonordisk-us.com)
Posted in
Share this